取卵當天及隨後3天注射含鈣注射液(Ca gluconate)可能可下降卵巢過度刺激之機率與嚴重度

Fertil Steril. 2015 Jan;103(1):101-5. doi: 10.1016/j.fertnstert.2014.09.046.

Calcium infusion for the prevention of ovarian hyperstimulation syndrome: a double-blind randomized controlled trial.

El-Khayat W1, Elsadek M2.

Author information

Abstract

OBJECTIVE:

To evaluate the role of calcium infusion as a preventive strategy of ovarian hyperstimulation syndrome (OHSS) in women at high risk in in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) treatment cycles.

DESIGN:

Double-blinded randomized controlled trial.

SETTING:

University hospital department of obstetrics and gynecology and private IVF center.

PATIENT(S):

Two hundred women at risk to develop OHSS undergoing IVF/ICSI treatment cycle.

INTERVENTION(S):

The intervention group (group 1; n = 100) received intravenous infusion of 10 mL 10% calcium gluconate in 100 mL 0.9% saline solution on the day of ovum pick-up (OPU) and days 1, 2, and 3 after, and the placebo group (group 2; n = 100) received 100 mL 0.9% saline solution on the day of OPU and days 1, 2, and 3 after.

MAIN OUTCOME MEASURE(S):

Incidence of OHSS.

RESULT(S):

OHSS incidence was significantly higher in the placebo group (group 2) than in the calcium infusion group (group 1): 23 (23%) vs. 7 (7%); moderate OHSS was significantly higher in group 2 than in group 1: 8 (8%) vs. 1 (1%); and severe OHSS was significantly higher in group 2 than in group 1: 4 (4%) vs. 0.

CONCLUSION(S):

Intravenous calcium infusion effectively reduced the incidence of OHSS development without reduction in the pregnancy rate.